AstraZeneca Partners For Stem Cell Cardiovascular Therapy
Genetic Engineering & Biotechnology News (GEN) - 07-May-2018AstraZeneca will develop cardiovascular and catheter-based therapies. Using Procella Therapeutic...
Join the club for FREE to access the whole archive and other member benefits.
Professor of Cardiovascular Research at Karolinska Institutet.
The central scientific interest of the Chien lab is to understand heart development at the molecular and cellular level, with the ultimate goal of applying the developmental principles, logic, pathways, technology, and model systems to unravel human heart disease.
Our research group plans to provide new insight into several areas of human cardiogenesis, ranging from molecular decoding of human heart development to developing completely novel technologies to control gene expression in the intact heart in vivo.
Professor Chien's lab is split jointly between the Solna (CMB) and the Huddinge (ICMC) campuses at Karolinska Institutet. Although the two labs act as one, CMB focuses primarily on molecular biology, while ICMC is more translational research. This arrangement gives the Chien lab a unique advantage in the field of regenerative cardiology.
Visit website: https://staff.ki.se/people/kenchi
See also: Karolinska Institutet - Public Medical university
Details last updated 13-Feb-2020
AstraZeneca will develop cardiovascular and catheter-based therapies. Using Procella Therapeutic...